Zanubrutinib Plus Sonrotoclax in Patients With Treatment-Naïve CLL/SLL
Nicole Lamanna, MD, discusses the results from the ongoing BGB-11417-101 study investigating combination zanubrutinib plus sonrotoclax in patients with treatment-naïve CLL/SLL.
Source: onclive.com